+86-400-890-9989
Product Catalog
> Angiotensinogen Protein & Antibody (Angiotensin, SerpinA8) Angiotensinogen Protein & Antibody (Angiotensin, SerpinA8)
Serpin peptidase inhibitor, clade A, member 8
Angiotensinogen Products
Angiotensinogen Protein, Recombinant
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Angiotensinogen/SerpinA8 | Human | Angiotensinogen/SerpinA8 Protein, Recombinant | 10994-H08H |
| Angiotensinogen/SerpinA8 | Mouse | Angiotensinogen/SerpinA8 Protein, Recombinant | 50337-M08H |
Angiotensinogen Antibody
| Molecule | Application | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Human Angiotensinogen/SerpinA8 |
WB, ELISA | Mouse Monoclonal Antibody | 10994-MM01 |
| Human Angiotensinogen/SerpinA8 |
WB, ELISA | Angiotensinogen/SerpinA8 Antibody, Rabbit MAb | 10994-R001 |
| Human Angiotensinogen/SerpinA8 |
WB, ELISA | Rabbit Polyclonal Antibody | 10994-RP01 |
| Human Angiotensinogen/SerpinA8 |
WB, ELISA | Rabbit Polyclonal Antibody (Antigen Affinity Purified) | 10994-RP02 |
| Mouse Angiotensinogen/SerpinA8 |
WB, ELISA | Angiotensinogen / SerpinA8 / AGT Antibody (Antigen Affinity Purified) | 50337-RP02 |
Angiotensinogen cDNA Clone
| Molecule | Species | Description //For Detailed Info. and Price------CLICK! | Cat. No |
| Angiotensinogen/SerpinA8 | Human | Homo sapiens Angiotensinogen/SerpinA8 cDNA Clone(NM_000029.3) (NM_001100607.1) | HG10994-M |
Angiotensinogen Related Areas
Cardiovascular>>Blood Pressure Regulation>>Angiotensinogen/SerpinA8
Enzyme>>Protease & Regulator>>Serine Protease & Regulator>>Serpin Superfamily>>Angiotensinogen/SerpinA8
Angiotensinogen Alternative Names
Angiotensinogen, AGT, SERPINA8, angiotensin I, angiotensin II, ANHU, FLJ92595, FLJ97926, alpha-1 antiproteinase, antitrypsin, pre-angiotensinogen, serine (or cysteine) proteinase inhibitor [Homo sapiens]
Angiotensinogen, Agt, Serpina8, angiotensin ll, AI265500, AngII, Aogen [Mus musculus]
Angiotensinogen Related Products
Protein Products
Antibody Products
cDNA Clone Products
Angiotensinogen Background
Angiotensinogen, also known as AGT and SerpinA8, is a member of the serpin family. It is an α-2-globulin that is produced constitutively and released into the circulation mainly by the liver. Angiotensinogen is a essential component of the renin-angiotensin system (RAS) and a potent regulator of blood pressure. Angiotensinogen can be schematically considered to consist of a combination of an angiotensin I (Ang I) function, located at the N-terminal end, and the presence of a serpin (serine protease inhibitor) structure at the opposite end. Angiotensinogen is cleaved into three chains: Angiotensin-1 (Ang I), Angiotensin-2 (Ang II), and Angiotensin-3 (Ang III). Angiotensin-1 is a substrate of ACE (angiotensin converting enzyme) that removes a dipeptide to yield the physiologically active peptide angiotensin-2. Angiotensin-1 and angiotensin-2 can be further processed to generate angiotensin-3, angiotensin-4. Angiotensin 1-7 is cleaved from angiotensin-2 by ACE2. Angiotensin-2 acts directly on vascular smooth muscle as a potent vasoconstrictor, affects cardiac contractility and heart rate through its action on the sympathetic nervous system. Defects in AGT are associated with susceptibility to essential hypertension and renal tubular dysgenesis (RTD). Several serpins (antithrombin, maspin, pigment epithelial-derived factor, and kallistatin) have been recently shown to exert an antiangiogenic activity, suggesting a common mechanism of endothelial cell proliferation and migration. Angiotensinogen/AGT and its renin-cleaved product, des(Ang I)AGT, are also angiogenesis inhibitors, both in vitro and in vivo at concentrations within the range of those observed in plasma. The Angiotensinogen products, that is angiotensin II and possibly angiotensin II-related products, have been found to act locally in modulating adipose tissue growth in an autocrine/paracrine manner. The transient or chronic overexpression of angiotensinogen in adipose tissue favors lipogenesis in adipocytes and leads to a 'vicious' circle whereby adipose tissue development is further increased.
Angiotensinogen Related Studies
- Ailhaud G, et al. (2002) Angiotensinogen, adipocyte differentiation and fat mass enlargement. Curr Opin Clin Nutr Metab Care. 5(4): 385-9.
- Corvol P, et al. (2003) Inhibition of angiogenesis: a new function for angiotensinogen and des(angiotensin I)angiotensinogen. Curr Hypertens Rep. 5(2): 149-54.
Angiotensinogen related areas, pathways, and other information
